Upgrade to Chrome Upgrade to Firefox Upgrade to Microsoft Edge Upgrade to Safari
Skip to content
  • Services
    • Overview
    • Global Market Access
    • Evidence Review & Synthesis
    • Health Economic Modelling
    • Health Technology Assessment
    • Data Science & Analytics
    • Value Communication
    • Overview
    • Global Market Access
    • Evidence Review & Synthesis
    • Health Economic Modelling
    • Health Technology Assessment
    • Data Science & Analytics
    • Value Communication
    • Global Market Access
    • Evidence Review & Synthesis
    • Health Economic Modelling
    • Health Technology Assessment
    • Data Science & Analytics
    • Value Communication
  • About
    • About HEOR
    • Our Ethos
    • Team
    • Case Studies
    • About HEOR
    • Our Ethos
    • Team
    • Case Studies
    • About HEOR
    • Our Ethos
    • Team
    • Case Studies
  • Insights
    • Industry Insights
    • News
    • Publications
    • Industry Insights
    • News
    • Publications
    • Insights
    • News
    • Publications
  • Join us
    • Our people
    • Learn & develop
    • Candidate journey
    • Latest vacancies
    • Our people
    • Learn & develop
    • Candidate journey
    • Latest vacancies
    • Our people
    • Learn & develop
    • Candidate journey
    • Latest vacancies
  • Contact

Detecting transthyretin amyloid cardiomyopathy (ATTR-CM) using machine learning: an evaluation of the performance of an algorithm in a UK setting

Real-world treatment sequencing and survival in previously treated advanced renal cell carcinoma patients receiving nivolumab monotherapy: a UK retrospective cohort study

Impact of delayed diagnosis and misdiagnosis for patients with transthyretin amyloid cardiomyopathy (ATTR-CM): a targeted literature review

Estimating the health benefits of timely diagnosis and treatment of transthyretin amyloid cardiomyopathy

Economic evaluation of single versus combination immuno-oncology therapies: application of a novel modelling approach in metastatic melanoma

Treatment patterns and health outcomes in metastatic renal cell carcinoma patients treated with targeted systemic therapies in the UK

Brentuximab vedotin for the treatment of patients with relapsed or refractory Hodgkin lymphoma after autologous stem cell transplantation

Cohort versus patient level simulation for the economic evaluation of single versus combination immuno-oncology therapies in metastatic melanoma

  • Services
  • Insights
  • Case studies
  • Services
  • Insights
  • Case studies
  • About us
  • Contact us
  • About us
  • Contact us
  • Privacy policy
  • Environmental policy
  • Privacy policy
  • Environmental policy
© 2026 Health Economics and Outcomes Research LTD, All Rights Reserved
GDPR verified badge
EcoVadis Committed badge for ESG performance
Carbon disclosure toolkit badge
Science Based Targets initiative (SBTi) validation logo

WE ARE COMMITTED TO SCIENCE-BASED CLIMATE TARGETS VALIDATED BY THE SBTI

  • Services
    • Global Market Access
    • Evidence Review & Synthesis
    • Health Economic Modelling
    • Health Technology Assessment
    • Data Science & Analytics
    • Value Communication
  • About
    • About HEOR
    • Our Ethos
    • Team
    • Case Studies
  • Insights
    • Insights
    • News
    • Publications
  • Join us
    • Our people
    • Learn & develop
    • Candidate journey
    • Latest vacancies
  • Contact